Zacks Investment Research on MSN
Agios Pharmaceuticals stock declines 23% in 6 months: Here's why
Shares of Agios Pharmaceuticals AGIO have plunged 23% over the past six months, primarily due to pipeline and regulatory setbacks, which have dampened investor confidence in the company’s near-term ...
Abstract: Recent progress in research on deep graph networks (DGNs) has led to a maturation of the domain of learning on graphs. Despite the growth of this research field, there are still important ...
Abstract: Recently, ChatGPT, a representative large language model (LLM), has gained considerable attention. Due to their powerful emergent abilities, recent LLMs are considered as a possible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results